Remove 2014 Remove FDA Remove Licensing
article thumbnail

Q&A: George Church on Genomics of Cognitive Enhancement

Bill of Health

In these spin-offs, does one approach the Church Lab with a request for licensing or are there collaboration agreements with the Harvard Office of Technology Review? The practicality I’ve noticed over the years is that no matter what we aim at, there’s the very severe, shorter-term FDA trial. In 2014 CRISPR gene drives.

FDA 240
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – June

SQA

United States Food and Drug Administration (FDA) – Regulations and Guidances. FDA Proposes Benefit-Risk Considerations for Product Quality Assessments, 20 June 2022. The FDA is announcing the availability of a draft guidance for industry entitled Conducting Remote Regulatory Assessments, Question and Answers.

FDA 91
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – September/October

SQA

26 of 2014. Since health authorities have not yet published guidelines for a comprehensive control strategy specific to microbiological topics for ATMPs, it is up to the individual ATMP sponsor or license holder to apply these compendial references properly. United States Food and Drug Administration (FDA) – Regulations and guidance.

FDA 40
article thumbnail

FDA Oversight of AI Software Developed by Health Care Providers

Health Law Advisor

But the question is, to what extent do health care providers need to worry about FDA requirements as they use AI? FDA has been regulating machine learning algorithms used in a clinical context for decades. It’s important to understand that FDA regulation isn’t punitive in the sense that it’s only intended to apply to bad people.

FDA 98
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – March And April

SQA

The company did not have a written procedure in place for the provision of information related to serious risk of injury to health, contrary to what was committed to on it establishment license application. The name and address of manufacturers provided by the company on its establishment license application were not accurate.

FDA 40
article thumbnail

SQA Regulatory Surveillance Summary for May and June 2024

SQA

Most synthetic injectable peptides are regulated as prescription drugs in Canada and require a prescription from a licensed healthcare professional. 68: Risk-Based Approach for Prevention and Management of Drug Shortages was originally developed in 2014. Some peptides can be produced for use in medications.

FDA 52
article thumbnail

SQA Regulatory Surveillance Summary 4 | Monthly Update 2021

SQA

Commission in March 2015 after the publication, in December 2014, of the Q3D Guideline on Elemental Impurities (EI) by the International Council for Harmonization (ICH). FDA plant inspection and pay $50 million in fines and forfeiture. Guidance on the Licensing of Biosimilar Products, 06 May 2021.